Skip to main content
. 2017 Apr 25;61(6):627–635. doi: 10.1111/aas.12897

Table 1.

Baseline demographics

RH (n = 40) UUS (n = 43) P value
Missing, n Missing, n
Age, mean (95% CI) 53.6 (49.6–58.1) 0 49.2 (44.3–54.1) 0 0.184
Male gender, n (%) 28 (70.0) 0 33 (76.7) 0 0.410
Body weight (kg), mean (95% CI) 81.1 (75.3–86.9) 1 87.9 (79.3–96.5) 0 0.198
SAPS II, mean (95% CI) 49.3 (43.7–55.0) 5 43.2 (39.2–47.2) 2 0.070
90 days mortality, n (%) 11 (27.5) 0 11 (25.6) 0 0.843
CRRT, n (%) 16 (40.0) 20 (46.5)
Patients with AKI, n (%) according to RIFLE‐criteria 25 (64.1) 1 24 (55.8) 0 0.445
Diagnosis, n (%)
Cardiovascular 3 (7.5) 4 (9.3) 0.771
Hematological 7 (17.5) 0 (0) 0.006
Neurological 5 (12.5) 3 (7.0) 0.400
Pneumonia 8 (20.0) 2 (4.7) 0.037
Septicemia 14 (35.0) 6 (14.0) 0.027
Postoperative complications 13 (32.5) 16 (37.2) 0.658
Trauma 0 (0) 19 (44.2) < 0.001
Others 14 (35.0) 9 (20.9) 0.156
CRP, mean (95% CI) 143.4 (113.7–173.2) 0 232.7 (195.3–270.1) 0 0.000
S‐creatinine (μmol/l), mean (95% CI)
Total average 138.4 (91.9–184.9) 0 133.9 (102.8–165.0) 0 0.869
CRRT 216.8 (109.1–324.6) 185.8 (130.3–241.3) 0.570
Non‐CRRT 86.1 (67.2–105.1) 88.7 (66.2–111.3) 0.855
S‐bilirubin (μmol/l), median, (IQR) 43.0 (10.0–131.0) 1 15.0 (9.0–34.0) 0 0.035

CI, Confidence interval; RH, Rikshospitalet; UUS, Ullevaal Hospital; SAPS, Simplified Acute Physiological Score; CRRT, continuous renal replacement therapy; AKI, acute kidney injury; RIFLE, Risk, Injury, and Failure; and Loss; and End‐stage kidney disease; IQR, inter‐quartile range.